Results 21 to 30 of about 1,326 (158)
Anti-TNF-Alpha Associated Central Nervous System Demyelination. Drug-Induced Demyelination or Multiple Sclerosis Trigger? A Case Series. [PDF]
Clin Case RepABSTRACT Adalimumab is a monoclonal antibody that targets TNF‐α and is effective in treating several autoimmune disorders, including non‐infectious uveitis; however, it has been associated with demyelinating lesions. This study presents two cases of CNS demyelination in patients who consumed adalimumab. First, an 18‐year‐old man presented with subacute
Abutorabi-Zarchi M, Ziyaei A, Ghane D.
europepmc +2 more sources
Tumefactive multiple sclerosis plaque [PDF]
Journal of Neurology, Neurosurgery & Psychiatry, 2002 We present a case of a large solitary demyelinating plaque in the brain masquerading as tumour. A 34 year old healthy woman presented with sudden onset of left hemiparesis. Subsequent MRI of the brain showed a single large 2.5 cm right sided enhancing lesion within the white matter of the parietal lobe …
S, Khoshyomn, S P, Braff, P L, Penar
openaire +2 more sources
Tumefactive: A Rare First presentation of Multiple Sclerosis [PDF]
Disease and Diagnosis, 2018 Tumefactive demyelinating lesions are a rare presentation of multiple sclerosis (MS). Diagnosis of tumefactive is commonly carried out using magnetic resonance image (MRI). Tumefactive diagnosis is difficult because of may similar to the clinical and MRI
Athena Sharifi Razavi +3 more
doaj +1 more source
Tumefactive multiple sclerosis
Romanian Neurosurgery, 2021 Tumefactive multiple sclerosis is a rare variant of multiple sclerosis, characterized by the presence of brain lesions that may be solitary or multiple. Considering that these lesions have a pseudotumoral appearance, it is a challenge to differentiate them from central nervous system neoplasms through neuroimaging.
Michael Gregorio Ortega-Sierra +11 more
openaire +1 more source
Pediatric tumefactive multiple sclerosis - a challenging case [PDF]
Romanian Journal of Neurology, 2014 Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system which is often diagnosed in young adults. We present a case of tumefactive multiple sclerosis in a child, an unusual form of presentation of MS, especially at ...
Smaranda Nita +4 more
doaj +1 more source
When tumefactive demyelination is truly a tumor: case report of a radiographic misdiagnosis
CNS Oncology, 2021 Oligodendrogliomas are slow-growing tumors that account for 15–20% of gliomas. This case report describes the case of an adult male patient diagnosed initially with tumefactive demyelination and multiple sclerosis, which was subsequently found to be a ...
Breanna Taylor +2 more
doaj +1 more source
Neurology International, 2021 Distinguishing between tumefactive demyelinating lesions (TDLs) and brain tumors in multiple sclerosis (MS) can be challenging. A progressive course is highly common with brain tumors in MS and no single neuroimaging technique is foolproof when ...
Chantal Kahovec +2 more
doaj +1 more source
Case Reports in Neurology, 2023 Introduction: Baló’s concentric sclerosis (BCS) is a rare subtype of multiple sclerosis characterized by inflammatory demyelination within the central nervous system.
Nexhmedin Shala +7 more
doaj +1 more source
Sensory Useless Hand of Oppenheim: A Rare Case [PDF]
Journal of Clinical and Diagnostic Research, 2020 Sensory useless hand of Oppenheim was first described in 1911. It is an unusual presentation of Multiple Sclerosis. It is characterised as a functional disorder with loss of sensory modalities and preserved motor functions.
Varsha Muddasani +1 more
doaj +1 more source
Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis [PDF]
Internal Medicine, 2017 Masataka Nakamura +2 more
exaly +2 more sources